Tumor Ablation Market Size To Reach $4.08 Billion By 2030

February 2025 | Report Format: Electronic (PDF)

Tumor Ablation Market Growth & Trends

The global tumor ablation market size is estimated to reach USD 4.08 billion by 2030, registering to grow at a CAGR of 13.8% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing incidence of cancer and high demand for effective treatment options are the major factors contributing to market growth. According to the International Agency for Research on Cancer, 19,292,789 cancer cases were reported in 2020, and are expected to reach 50,550,287 by 2025. Breast, lung, colorectum, prostate, and stomach are the most common cancers reported. The growing preference for minimally invasive procedures, attributed to advantages like fast recovery, patient comfort, and shorter turnaround times, is projected to drive demand for advanced tumor ablation techniques.

Furthermore, the integration of such devices with highly effective interventional imaging technologies, such as ultrasound, MRI, and CT, is poised to bring about a transformation in ablation procedures conducted in outpatient settings. This shift is anticipated to substantially reduce costs for patients, including expenses related to hospital stays. Government-sponsored initiatives, including screening programs, awareness campaigns, and specific cancer schemes, are projected to increase the number of diagnosed cases. For instance, in 2019, the National Health Scheme (NHS) in England initiated lung cancer screening programs in selected regions. Such initiatives are expected to increase the demand for early-stage cancer management, thus driving market growth.

key Request a free sample copy or view report summary: Tumor Ablation Market Report

Tumor Ablation Market Report Highlights

Based on technology, the radiofrequency tumor ablation segment led the market with the largest revenue share of 32.8% in 2024.
Based on technology, the percutaneous ablation segment accounted for the largest revenue share in 2024.
Based on application, the other segments accounted for the largest market share in 2024. The other segment includes various types of cancer, such as bone metastasis and ENT cancer.
North America dominated the tumor ablation market with the largest revenue share of 34.33% in 2024.